.
MergerLinks Header Logo

New Deal


Cover Image NOVAVAX
NOVAVAX

NOVAVAX

Summary


Novavax is a late-stage biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.

Deals Overview

Total Deals2
Valued Deals2
Total Value£295M
Avg. Deal Size£148M

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US